Sean Ainsworth

Director/Board Member at OPUS GENETICS, INC.

Net worth: 1 M $ as of 2026-05-30

58 year

94 connections

Health Technology

Consumer Services

Health Services

Profile

Sean Ainsworth was the founder of Compendia Bioscience, Inc. (founded 2006), Ray Therapeutics, Inc. (founded 2021) where the title held was Chairman, RetroSense Therapeutics LLC (founded 2009) where the title held was Chairman & Chief Executive Officer, and Ainsworth Bioconsulting LLC (founded 2004) where the title held was Principal.
Mr. Ainsworth is currently Chairman & Chief Executive Officer at Immusoft Corp.
since 2018 and Lead Independent Director at Opus Genetics, Inc. since 2018.
Former positions include Chief Executive Officer at Genevivo LLC from 2007 to 2008 and Executive Director-Clinical Development at Allergan UC from 2016 to 2017.
Education includes an MBA from Washington University in St. Louis conferred in 2002 and an undergraduate degree from the University of California San Diego conferred in 1996.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
OPUS GENETICS, INC. 0.4%	2026-04-19	321,692 ( 0.4% )	1 M $	2026-05-30

Sean Ainsworth active positions

Companies	Position	Start
OPUS GENETICS, INC.	Director/Board Member	2018-03-31
Immusoft Corp. Immusoft Corp. Medical/Nursing ServicesHealth Services Provides disease curing services through immune cells	Chief Executive Officer	2018-01-04

All active positions of Sean Ainsworth

Former positions of Sean Ainsworth

Companies	Position	End
ALLERGAN PLC	Corporate Officer/Principal	2016-12-31
RetroSense Therapeutics LLC RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology Operates as a biotechnology company that focuses on developing gene therapy	Chief Executive Officer	2015-12-31
Ainsworth Bioconsulting LLC	Founder	2012-05-31
Genevivo LLC	Chief Executive Officer	2007-12-31
Ray Therapeutics, Inc. Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops optogenetic gene therapies for patients with blinding diseases	Founder	-

See the detail of Sean Ainsworth's experience

Training of Sean Ainsworth

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sean Ainsworth's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Washington University in St. Louis Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
RetroSense Therapeutics LLC RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology Operates as a biotechnology company that focuses on developing gene therapy	Health Technology
Immusoft Corp. Immusoft Corp. Medical/Nursing ServicesHealth Services Provides disease curing services through immune cells	Health Services
University of California San Diego University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Allergan Ltd. (Ireland) Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products	Health Technology
Compendia Bioscience, Inc. Compendia Bioscience, Inc. Information Technology ServicesTechnology Services Provides information solutions for oncology drug discovery	Technology Services
Ocuphire Pharma, Inc. Ocuphire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals for eye disorders	Health Technology
Ainsworth Bioconsulting LLC
Genevivo LLC
Ray Therapeutics, Inc. Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops optogenetic gene therapies for patients with blinding diseases	Commercial Services